A group of 18 colorectal cancer patients experienced complete remission after taking the experimental drug dostarlimab for ...
A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful, ...
Get Instant Summarized Text (Gist) An experimental drug, GL-II-73, shows potential in reversing memory loss and cognitive decline in Alzheimer's disease, as demonstrated in a mouse model. The drug ...
An Experimental Cancer Vaccine Turned Tumor Cells Into Traitors ... some patients were also given a drug that boosts the immune system’s response to cancer, called pembrolizumab.
The stop-work order on U.S.A.I.D.-funded research has left thousands of people with experimental drugs and devices in their ...
2014). However, the difficulty of producing homogeneous spheres in a reproducible manner combined with the insufficiency of stable experimental data can prove to be a challenge during the application ...
A paradigm-shifting study from the Centre for Addiction and Mental Health (CAMH) shows an experimental drug, GL-II-73, has the potential to restore memory and cognitive function in a mouse model ...
Three trials presented at ASCO GI 2025 will change practice and improve the treatment of colorectal cancer, according to experts.
CardioOncology, shows that administration of the SGLT2 inhibitor empagliflozin to pigs receiving anthracyclines preserves ...
A Columbia-led study uncovers how gliomas cause seizures and cognitive impairments by disrupting brain activity. Using ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果